CK Life Sciences (00775) said its profit attributable to shareholders for the six months ended 30 June 2016 rose 4.9% year-on-year to HK$187 million.
Basic and diluted earnings per share were HK1.95 cents.
The revenue was HK$2,528 million, an increase of 3.2% from a year earlier.
No interim dividend will be distributed.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
